• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病伴巨大心尖室壁瘤和附壁血栓。

Hypertrophic cardiomyopathy with a large apical ventricular aneurysm and mural thrombus.

作者信息

Raza Munis, Chalfoun Nagib, Wissam Abdallah, Hashmi Hamza, McNamara Richard

机构信息

Grand Rapids Medical Education Partners/Michigan State University Internal Medicine Residency, Grand Rapids, Michigan.

Frederik Meijer Heart and Vascular Institute, Spectrum Health, Grand Rapids, Michigan.

出版信息

Glob Cardiol Sci Pract. 2018 Mar 14;2018(1):9. doi: 10.21542/gcsp.2018.9.

DOI:10.21542/gcsp.2018.9
PMID:29644236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5857068/
Abstract

Hypertrophic cardiomyopathy (HCM) is characterized by increased left ventricular wall thickness in the absence of any other identifiable cause of thickness. It predisposes the patient to increased risk of sudden cardiac death (SCD) due to fatal arrhythmias. Approximately 2% of the HCM patients have left ventricular apical aneurysm. CMR imaging is better in identifying this apical aneurysm as compared to echocardiogram. This apical aneurysm, which can be akinetic or dyskinetic, increases the risk of disease-related adverse events as compared to general HCM. These adverse disease-related events include SCD, thromboembolism, and symptoms of heart failure. We report a rare case of hypertrophic cardiomyopathy in association with Williams-Beuren Syndrome. On CMR imaging, patient was found to have a large apical aneurysm and mid-ventricular obstruction with underlying thrombus. He was started on oral anticoagulation, and ICD was recommended.

摘要

肥厚型心肌病(HCM)的特征是左心室壁厚度增加,且不存在任何其他可识别的导致心室壁增厚的原因。它使患者因致命性心律失常而发生心源性猝死(SCD)的风险增加。约2%的HCM患者有左心室心尖部室壁瘤。与超声心动图相比,心脏磁共振成像(CMR)在识别这种心尖部室壁瘤方面表现更佳。这种心尖部室壁瘤可表现为运动减弱或运动障碍,与一般的HCM相比,它会增加疾病相关不良事件的风险。这些与疾病相关的不良事件包括SCD、血栓栓塞和心力衰竭症状。我们报告一例罕见的肥厚型心肌病合并威廉斯-贝伦综合征的病例。在CMR成像检查中,发现该患者有一个巨大的心尖部室壁瘤和心室中部梗阻,并伴有潜在血栓形成。患者开始接受口服抗凝治疗,并建议植入植入式心律转复除颤器(ICD)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/5857068/40cde2dc5e4f/gcsp-2018-1-e201809-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/5857068/606f372792a7/gcsp-2018-1-e201809-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/5857068/87afb289f8d1/gcsp-2018-1-e201809-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/5857068/40cde2dc5e4f/gcsp-2018-1-e201809-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/5857068/606f372792a7/gcsp-2018-1-e201809-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/5857068/87afb289f8d1/gcsp-2018-1-e201809-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c08/5857068/40cde2dc5e4f/gcsp-2018-1-e201809-g003.jpg

相似文献

1
Hypertrophic cardiomyopathy with a large apical ventricular aneurysm and mural thrombus.肥厚型心肌病伴巨大心尖室壁瘤和附壁血栓。
Glob Cardiol Sci Pract. 2018 Mar 14;2018(1):9. doi: 10.21542/gcsp.2018.9.
2
Clinical Characteristics and Prognostic Importance of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy.肥厚型心肌病患者左心室心尖部室壁瘤的临床特征及预后意义
JACC Cardiovasc Imaging. 2022 Oct;15(10):1696-1711. doi: 10.1016/j.jcmg.2022.03.029. Epub 2022 Jun 15.
3
Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.左心室心尖部瘤在肥厚型心肌病中的预后作用:系统评价和荟萃分析。
Int J Cardiol. 2021 Jun 1;332:127-132. doi: 10.1016/j.ijcard.2021.03.056. Epub 2021 Mar 29.
4
Doppler Systolic Signal Void in Hypertrophic Cardiomyopathy: Apical Aneurysm and Severe Obstruction without Elevated Intraventricular Velocities.肥厚型心肌病中的多普勒收缩期信号缺失:心尖部瘤样扩张和严重梗阻而心室速度不高。
J Am Soc Echocardiogr. 2015 Dec;28(12):1462-73. doi: 10.1016/j.echo.2015.08.015. Epub 2015 Sep 28.
5
Clinical Profile and Prognosis of Left Ventricular Apical Aneurysm in Hypertrophic Cardiomyopathy.
Am J Med Sci. 2016 Jan;351(1):101-10. doi: 10.1016/j.amjms.2015.10.006.
6
[Comparison on CMR characteristics and clinical prognosis between hypertrophic cardiomyopathy patients with and without left ventricular apical aneurysms].肥厚型心肌病伴与不伴左心室心尖部室壁瘤患者的心脏磁共振特征及临床预后比较
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Mar 24;47(3):204-208. doi: 10.3760/cma.j.issn.0253-3758.2019.03.005.
7
[Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].[2014年欧洲指南心脏性猝死风险预测模型(HCM Risk-SCD)对中国肥厚型心肌病患者的预测价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Dec 24;45(12):1033-1038. doi: 10.3760/cma.j.issn.0253-3758.2017.12.006.
8
Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: Importance of multi-modality imaging.伴有左心室心尖部室壁瘤的肥厚型心肌病:多模态成像的重要性
Echocardiography. 2017 Sep;34(9):1392-1395. doi: 10.1111/echo.13581. Epub 2017 Jun 1.
9
Subaortic and mid-ventricular obstructive hypertrophic cardiomyopathy with an apical aneurysm: a case report.伴有心尖部动脉瘤的主动脉瓣下及心室中部梗阻性肥厚型心肌病:一例报告
Cardiovasc Ultrasound. 2006 Mar 22;4:15. doi: 10.1186/1476-7120-4-15.
10
Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.肥厚型心肌病伴左心室心尖部瘤:风险分层和管理的意义。
J Am Coll Cardiol. 2017 Feb 21;69(7):761-773. doi: 10.1016/j.jacc.2016.11.063.

引用本文的文献

1
Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning.基于集成机器学习的肥厚型心肌病诊断基因生物标志物预测。
J Int Med Res. 2023 Nov;51(11):3000605231213781. doi: 10.1177/03000605231213781.
2
An Atypical Non-Cardiac Presentation of Hypertrophic Cardiomyopathy.肥厚型心肌病的一种非典型非心脏表现
Arq Bras Cardiol. 2023 Jun;120(6):e20220933. doi: 10.36660/abc.20220933.
3
Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.肥厚型心肌病的评估:新的超声心动图和 MRI 方法。

本文引用的文献

1
Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.肥厚型心肌病伴左心室心尖部瘤:风险分层和管理的意义。
J Am Coll Cardiol. 2017 Feb 21;69(7):761-773. doi: 10.1016/j.jacc.2016.11.063.
2
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).2014年欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗指南:欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
3
Curr Cardiol Rep. 2019 Jun 26;21(8):75. doi: 10.1007/s11886-019-1173-1.
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断与治疗指南:执行摘要:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 Dec 13;124(24):2761-96. doi: 10.1161/CIR.0b013e318223e230. Epub 2011 Nov 8.
4
Cardiomyopathy and sudden cardiac death in Williams-Beuren-syndrome.
Int J Cardiol. 2012 May 3;156(3):e53-4. doi: 10.1016/j.ijcard.2011.08.044. Epub 2011 Sep 13.
5
Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.肥厚型心肌病中左心室心尖部室壁瘤的患病率、临床意义及自然病史
Circulation. 2008 Oct 7;118(15):1541-9. doi: 10.1161/CIRCULATIONAHA.108.781401. Epub 2008 Sep 22.
6
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.肥厚型心肌病中心律失常的发生情况及频率与心血管磁共振延迟强化的关系
J Am Coll Cardiol. 2008 Apr 8;51(14):1369-74. doi: 10.1016/j.jacc.2007.11.071.
7
Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者报告生存率的历史趋势。
Heart. 2006 Jun;92(6):785-91. doi: 10.1136/hrt.2005.068577. Epub 2005 Oct 10.